ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,385Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 617

$651K Total Retail Price of All Prescriptions

Rank: 34 out of 617

655 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 655 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 655 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 12,127 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
FUROSEMIDE 516 487 1 4
LISINOPRIL 505 425 2 5
WARFARIN SODIUM 502 483 3 7
AMLODIPINE BESYLATE 455 424 4 6
LEVOTHYROXINE SODIUM 419 378 5 1
OMEPRAZOLE 412 352 6 3
ATENOLOL 357 344 7 17
HYDROCODONE-ACETAMINOPHEN 322 255 S3 8 8
TRAMADOL HCL 313 274 9 15
METFORMIN HCL 293 262 10 9
SIMVASTATIN 273 240 11 2
RISPERIDONE 259 189 12 71
POTASSIUM CHLORIDE 235 217 13 10
MIRTAZAPINE 223 216 14 50
METOPROLOL TARTRATE 222 207 15 11
RANITIDINE HCL 214 131 16 40
SERTRALINE HCL 212 193 17 20
ZOLPIDEM TARTRATE 170 146 18 23
POLYETHYLENE GLYCOL 3350 167 110 19 32
TAMSULOSIN HCL 159 132 20 26
METOPROLOL SUCCINATE 157 134 21 12
PREDNISONE 156 144 22 31
CARVEDILOL 142 138 23 19
HYDROCHLOROTHIAZIDE 140 128 24 13
GABAPENTIN 132 97 25 16
TRIAMTERENE-HCTZ 129 117 26 47
LOSARTAN POTASSIUM 120 118 27 22
NEXIUM 118 91 28 43
CLOPIDOGREL 116 103 29 53
DONEPEZIL HCL 113 113 30 30
PLAVIX 109 103 31 86
SPIRONOLACTONE 95 89 32 42
CYMBALTA 92 58 33 49
PRAVASTATIN SODIUM 90 88 34 21
ALLOPURINOL 89 89 35 27
PAROXETINE HCL 86 86 36 62
CITALOPRAM HBR 85 77 37 18
ATORVASTATIN CALCIUM 85 65 37 14
SULFAMETHOXAZOLE-TRIMETHOPRIM 81 73 39 91
AMITRIPTYLINE HCL 79 66 R 40 56
GLIPIZIDE 78 77 41 82
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 60 42 29
LANTUS 75 65 42 39
DIVALPROEX SODIUM 73 27 44 111
CEFUROXIME 73 60 44 165
PHENYTOIN SODIUM EXTENDED 70 53 46 121
OXYBUTYNIN CHLORIDE 70 70 46 88
BENZTROPINE MESYLATE 68 25 R 48 163
ROPINIROLE HCL 68 64 48 66
KLOR-CON M20 67 51 50 116
TRAZODONE HCL 65 59 51 51
LYRICA 65 54 51 92
SPIRIVA 64 57 53 61
DICYCLOMINE HCL 64 44 53 226
ALBUTEROL SULFATE 62 36 55 112
ACTOS 61 53 56 85
CELEBREX 60 60 57 63
ABILIFY 59 41 58 131
MELOXICAM 59 46 58 24
TRIAMTERENE-HYDROCHLOROTHIAZID 57 56 60 122
ENALAPRIL MALEATE 56 55 61 34
FENTANYL 56 53 S2 61 45
FLUTICASONE PROPIONATE 56 45 61 36
DIGOXIN 55 51 64 48
FAMOTIDINE 51 27 65 54
DIOVAN 51 51 65 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.